Eurazeo SE logo

RF - Eurazeo SE Share Price

€61.35 -0.4  -0.6%

Last Trade - 4:35pm

Large Cap
Market Cap £4.06bn
Enterprise Value £8.18bn
Revenue £3.54bn
Position in Universe 123rd / 846
Unlock RF Revenue
Relative Strength (%)
1m +3.53%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -3.67%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2014 2015 2016 2017 2018 2019 2020E 2021E CAGR / Avg
4,086 1,985 2,181 3,440 4,366 4,681 4,507 4,731 +2.8%
-49.9 +64.8
Balance Sheet
FINANCIAL BRIEF: : For the six months ended 30 June 2020, Eurazeo SErevenues decreased 25% to EUR1.8B. Net loss totaledEUR389.8M vs. income of EUR176.1M. Revenues reflect EurazeoCapital segment decrease of 26% to EUR1.07B, Private Equity- Eurazeo PME segment decrease of 26% to EUR464.3M. Netloss reflects Impairment of goodwill/investments increasefrom EUR249K to EUR411.9M (expense), Capital Gain/Loss onthe Sec.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Latest News & Insights for RF
Graphical History


RF Revenue Unlock RF Revenue

Net Income

RF Net Income Unlock RF Revenue

Normalised EPS

RF Normalised EPS Unlock RF Revenue

PE Ratio Range

RF PE Ratio Range Unlock RF Revenue

Dividend Yield Range

RF Dividend Yield Range Unlock RF Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
RF EPS Forecasts Unlock RF Revenue
Profile Summary

Eurazeo SE is a France-based investment company. The Company owns a diversified portfolio of over 18 billion euro in assets under management in all business sectors, including 12,9 billion euro from third parties, invested in over 430 companies. The Company is active through five investment divisions: Eurazeo Capital with investments in Iberchem, Albingia or Europcar Mobility Group; Eurazeo PME with investments in Dessange or In’Tech Medical; Eurazeo Growth with investments in Doctolib or PayFit; Eurazeo Brands with investments in consumer and retail, including beauty with Pat McGrath Labs, fashion with Bandier, home with Herschel Supply, leisure, wellness or food companies with Q Mixers; Eurazeo Patrimoine with investments in real estate and infrastructure with C2S Group, Dazeo or Reden Solar. The Company supports also digital sector with Idinvest Venture through investments in Ornikar, an online driving school or M Pharma, a biopharmaceutical company.

Last Annual December 31st, 2019
Last Interim June 30th, 2020
Incorporated January 1, 1969
Public Since January 7, 1985
No. of Shareholders: n/a
No. of Employees: 22,361
Sector Financials
Industry Investment Banking & Investment Services
Index CAC Mid & Small , CAC All-tradable , FTSE Euromid , Sbf 120 Eclaireur ,
Exchange Euronext - Paris
Shares in Issue 75,807,044
Free Float (0.0%)
Eligible for
RF Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for RF
Upcoming Events for RF
Thursday 11th March, 2021
Full Year 2020 Eurazeo SE Earnings Release
Wednesday 28th April, 2021
Eurazeo SE Annual Shareholders Meeting
Thursday 20th May, 2021
Q1 2021 Eurazeo SE Corporate Sales Release
Frequently Asked Questions for Eurazeo SE
What is the Eurazeo SE share price?

As of 4:35pm, shares in Eurazeo SE are trading at €61.35, giving the company a market capitalisation of £4.06bn. This share price information is delayed by 15 minutes.

How has the Eurazeo SE share price performed this year?

Shares in Eurazeo SE are currently trading at €61.35 and the price has moved by -2.53% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Eurazeo SE price has moved by -6.84% over the past year.

What are the analyst and broker recommendations for Eurazeo SE?

Of the analysts with advisory recommendations for Eurazeo SE, there are there are currently 4 "buy" , 0 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Eurazeo SE is Buy. You can view the full broker recommendation list by unlocking its StockReport.

When will Eurazeo SE next release its financial results?

Eurazeo SE is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-06-30
What is the Eurazeo SE dividend yield?

Eurazeo SE does not currently pay a dividend.

Does Eurazeo SE pay a dividend?

Eurazeo SE does not currently pay a dividend.

When does Eurazeo SE next pay dividends?

Eurazeo SE does not currently pay a dividend.

How do I buy Eurazeo SE shares?

To buy shares in Eurazeo SE you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Eurazeo SE?

Shares in Eurazeo SE are currently trading at €61.35, giving the company a market capitalisation of £4.06bn.

Where are Eurazeo SE shares listed? Where are Eurazeo SE shares listed?

Here are the trading details for Eurazeo SE:

Country of listing: France
Exchange: PAR
Ticker Symbol: RF
What kind of share is Eurazeo SE?

Based on an overall assessment of its quality, value and momentum, Eurazeo SE is currently classified as a Style Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Eurazeo SE share price forecast 2021?

Shares in Eurazeo SE are currently priced at €61.35. At that level they are trading at 5.96% discount to the analyst consensus target price of 0.00.

Analysts covering Eurazeo SE currently have a consensus Earnings Per Share (EPS) forecast of -1.974 for the next financial year.

How can I tell whether the Eurazeo SE share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Eurazeo SE. Over the past six months, the relative strength of its shares against the market has been 23.01%. At the current price of €61.35, shares in Eurazeo SE are trading at 24.25% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Eurazeo SE PE Ratio?

We were not able to find PE ratio data for Eurazeo SE.

Who are the key directors of Eurazeo SE?

Eurazeo SE's management team is headed by:

Michel David-Weill - CSU
Olivier Merveilleux du Vignaux - VSU
Philippe Audouin - CFO
Virginie Morgon - CMG
Anne Lalou - IND
Victoire de Margerie - IND
Francoise Mercadal-Delasalles - IND
Bruno Roger - NEC
Anne Dias - IND
Marc Frappier - MAP
Frans Tieleman - MAP
Renaud Haberkorn - MAP
Jean-Charles Decaux - VSU
BENOIST Grossman - MAP
Sophie Flak - MAP
Who are the major shareholders of Eurazeo SE?

Here are the top five shareholders of Eurazeo SE based on the size of their shareholding:

Decaux Family Individual Investor
Percentage owned: 17.92% (14.2m shares)
David Weill Family Individual Investor
Percentage owned: 16.72% (13.2m shares)
Tikehau Investment Management Investment Advisor
Percentage owned: 6.57% (5.19m shares)
Richardson Family Individual Investor
Percentage owned: 3.48% (2.75m shares)
Rhône Capital LLC Private Equity
Percentage owned: 2.49% (1.97m shares)
Similar to RF
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.